Terms: = Breast cancer AND JAK1, ENSG00000162434, P23458, JTK3, JAK1B, JAK1A, 3716 AND Prognosis
16 results:
1. Combined effects of naringin and doxorubicin on the JAK/STAT signaling pathway reduce the development and spread of breast cancer cells.
Effat H; Abosharaf HA; Radwan AM
Sci Rep; 2024 Feb; 14(1):2824. PubMed ID: 38310190
[TBL] [Abstract] [Full Text] [Related]
2. SKAP1 Is a Novel Biomarker and Therapeutic Target for Gastric cancer: Evidence from Expression, Functional, and Bioinformatic Analyses.
Zhu L; Yu Q; Li Y; Zhang M; Peng Z; Wang S; Quan Z; Gao D
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511629
[TBL] [Abstract] [Full Text] [Related]
3. High expression of STAT3 within the tumour-associated stroma predicts poor outcome in breast cancer patients.
Morrow E; Pennel K; Hatthakarnkul P; Leslie H; Mallon E; Andersen D; Jamieson N; McMillan D; Roseweir A; Edwards J
Cancer Med; 2023 Jun; 12(12):13225-13240. PubMed ID: 37199043
[TBL] [Abstract] [Full Text] [Related]
4. CXCL9 influences the tumor immune microenvironment by stimulating JAK/STAT pathway in triple-negative breast cancer.
Wu L; Sun S; Qu F; Sun M; Liu X; Sun Q; Cheng L; Zheng Y; Su G
Cancer Immunol Immunother; 2023 Jun; 72(6):1479-1492. PubMed ID: 36472587
[TBL] [Abstract] [Full Text] [Related]
5. Identification of a combined apoptosis and hypoxia gene signature for predicting prognosis and immune infiltration in breast cancer.
Ren X; Cui H; Wu J; Zhou R; Wang N; Liu D; Xie X; Zhang H; Liu D; Ma X; Dang C; Kang H; Lin S
Cancer Med; 2022 Oct; 11(20):3886-3901. PubMed ID: 35441810
[TBL] [Abstract] [Full Text] [Related]
6. Opioids drive breast cancer metastasis through the δ-opioid receptor and oncogenic STAT3.
Tripolt S; Neubauer HA; Knab VM; Elmer DP; Aberger F; Moriggl R; Fux DA
Neoplasia; 2021 Feb; 23(2):270-279. PubMed ID: 33465556
[TBL] [Abstract] [Full Text] [Related]
7. Overexpression of miR-1225 promotes the progression of breast cancer, resulting in poor prognosis.
Gao S; Shi P; Tian Z; Yang X; Liu N
Clin Exp Med; 2021 May; 21(2):287-296. PubMed ID: 33423149
[TBL] [Abstract] [Full Text] [Related]
8. Association between body mass index and localization of breast cancer: results from a nationwide inpatient database in Japan.
Konishi T; Fujiogi M; Michihata N; Morita K; Matsui H; Fushimi K; Tanabe M; Seto Y; Yasunaga H
Breast Cancer Res Treat; 2021 Jan; 185(1):175-182. PubMed ID: 32949351
[TBL] [Abstract] [Full Text] [Related]
9. Extracellular ATP promotes breast cancer invasion and chemoresistance via SOX9 signaling.
Yang H; Geng YH; Wang P; Yang H; Zhou YT; Zhang HQ; He HY; Fang WG; Tian XX
Oncogene; 2020 Aug; 39(35):5795-5810. PubMed ID: 32724162
[TBL] [Abstract] [Full Text] [Related]
10.
Chen B; Lai J; Dai D; Chen R; Li X; Liao N
Aging (Albany NY); 2019 Dec; 11(23):11124-11135. PubMed ID: 31790361
[TBL] [Abstract] [Full Text] [Related]
11. Identification of genes associated with survival of breast cancer patients.
Liu M; Zhou S; Wang J; Zhang Q; Yang S; Feng J; Xu B; Zhong S
Breast Cancer; 2019 May; 26(3):317-325. PubMed ID: 30341748
[TBL] [Abstract] [Full Text] [Related]
12. Interleukin 7 receptor alpha Thr244Ile genetic polymorphism is associated with susceptibility and prognostic markers in breast cancer subgroups.
Vitiello GAF; Losi Guembarovski R; Amarante MK; Ceribelli JR; Carmelo ECB; Watanabe MAE
Cytokine; 2018 Mar; 103():121-126. PubMed ID: 28964592
[TBL] [Abstract] [Full Text] [Related]
13. IL15RA drives antagonistic mechanisms of cancer development and immune control in lymphocyte-enriched triple-negative breast cancers.
Marra P; Mathew S; Grigoriadis A; Wu Y; Kyle-Cezar F; Watkins J; Rashid M; De Rinaldis E; Hessey S; Gazinska P; Hayday A; Tutt A
Cancer Res; 2014 Sep; 74(17):4908-21. PubMed ID: 24980552
[TBL] [Abstract] [Full Text] [Related]
14. JAK2 expression is associated with tumor-infiltrating lymphocytes and improved breast cancer outcomes: implications for evaluating JAK2 inhibitors.
Miller CP; Thorpe JD; Kortum AN; Coy CM; Cheng WY; Ou Yang TH; Anastassiou D; Beatty JD; Urban ND; Blau CA
Cancer Immunol Res; 2014 Apr; 2(4):301-6. PubMed ID: 24764577
[TBL] [Abstract] [Full Text] [Related]
15. Aberrant expression of interleukin-7 (IL-7) and its signalling complex in human breast cancer.
Al-Rawi MA; Rmali K; Watkins G; Mansel RE; Jiang WG
Eur J Cancer; 2004 Mar; 40(4):494-502. PubMed ID: 14962714
[TBL] [Abstract] [Full Text] [Related]
16. Increased incidence of small and well-differentiated breast tumours in post-menopausal women following hormone-replacement therapy.
Manjer J; Malina J; Berglund G; Bondeson L; Garne JP; Janzon L
Int J Cancer; 2001 Jun; 92(6):919-22. PubMed ID: 11351317
[TBL] [Abstract] [Full Text] [Related]
